Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 2
2020 4
2021 3
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
Residual Site Radiotherapy After Immunochemotherapy in Primary Mediastinal B-Cell Lymphoma: A Monoinstitutional Retrospective Study.
DE Sanctis V, DI Rocco A, Cox MC, Valeriani M, Congedi FP, Anzellini D, Massaro M, Vullo G, Facondo G, DE Giacomo F, Alfò M, Prosperi D, Pizzichini P, Pelliccia S, Tafuri A, Martelli M, Osti MF. DE Sanctis V, et al. Among authors: anzellini d. In Vivo. 2020 May-Jun;34(3):1407-1413. doi: 10.21873/invivo.11921. In Vivo. 2020. PMID: 32354938 Free PMC article.
Clinical Outcomes and Toxicity of CT-guided High Dose-rate Brachytherapy in Women With Locally-advanced Cervical Cancer.
DE Sanctis V, Facondo G, Vullo G, Anzellini D, Sanguineti G, Nardangeli A, Marmiroli L, Tortoreto F, Gentile P, Annessi I, Donato V, Chiostrini C, Tombolini V, DE Felice F, Valeriani M, Osti MF. DE Sanctis V, et al. Among authors: anzellini d. Cancer Diagn Progn. 2023 Mar 3;3(2):194-200. doi: 10.21873/cdp.10201. eCollection 2023 Mar-Apr. Cancer Diagn Progn. 2023. PMID: 36875316 Free PMC article.
Stereotactic and Hypofractionated Radiotherapy Associated With Immune Checkpoint Inhibitor Drugs: Analysis of Local Control, Toxicity, and Outcome in a Single Research Centre Case Study.
Anzellini D, DE Sanctis V, Valeriani M, Reverberi C, Marinelli L, Massaro M, Vullo G, Facondo G, Sigillo RC, Tosi E, Osti MF. Anzellini D, et al. Anticancer Res. 2021 Oct;41(10):5107-5116. doi: 10.21873/anticanres.15327. Anticancer Res. 2021. PMID: 34593461 Clinical Trial.
One-week vaginal brachytherapy schedule as exclusive adjuvant post-operative treatment in intermediate- and high-intermediate-risk endometrial cancer patients.
De Sanctis V, Musio D, De Felice F, Marampon F, Valeriani M, Bonome P, Anzellini D, Facondo G, Vullo G, Massaro M, Di Staso M, Bonfili P, Chalaszczyk A, Gravina GL, Tombolini V, Osti MF. De Sanctis V, et al. Among authors: anzellini d. J Contemp Brachytherapy. 2020 Apr;12(2):124-130. doi: 10.5114/jcb.2020.94581. Epub 2020 Apr 30. J Contemp Brachytherapy. 2020. PMID: 32395136 Free PMC article.
Resilience in Radiotherapy Services During the COVID-19 Emergency: Collaboration Between the Regional Radiation Oncology Departments of Lazio, Abruzzo and Molise.
DE Angeli M, Anzellini D, Arcangeli G, Bianchi P, Chiostrini C, Ciabattoni A, Costa AM, Del Bufalo S, Deodato F, DE Paula U, D'Ugo C, Fedele F, Genovesi D, Gentile P, Gravina GL, Marmiroli L, Mirri MA, Ramella S, Rosetto ME, Santarelli M, Tombolini V, Trodella L, Valentini V, Osti MF, D'Angelillo RM. DE Angeli M, et al. Among authors: anzellini d. Anticancer Res. 2021 Jul;41(7):3561-3565. doi: 10.21873/anticanres.15143. Anticancer Res. 2021. PMID: 34230151
11 results